<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03891225</url>
  </required_header>
  <id_info>
    <org_study_id>2039CESC</org_study_id>
    <nct_id>NCT03891225</nct_id>
  </id_info>
  <brief_title>Prospective Study on Implantation of Amniotic Membrane (AM) Over Pancreatic Anastomosis After Pancreaticoduodenenctomy: Efficacy on Preventing Clinically Relevant Pancreatic Fistula</brief_title>
  <acronym>POPF</acronym>
  <official_title>Efficacy of Amniotic Membrane Implantation Over Pancreo-jejunal Anastomosis After Pancreaticoduodenectomy in Reducing Post-operative Pancreatic Fistula POPF.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Casa di Cura Dott. Pederzoli</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Fondazione Banca dei Tessuti di Treviso onlus</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Casa di Cura Dott. Pederzoli</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Post-operative pancreatic fistula (POPF) after pancreatic resection is a potentially
      life-threatening complication occuring in up to 27% of patients undergoing a pancreatic
      resection. Despite several strategies have been proposed further improvements are needed.
      Many studies suggest that amniotic membrane(AM) implantation is effective in tissue
      regeneration and prevention of fluid leakage at many surgical sites. However,the implantation
      of AM has never been used in pancreatic surgery.

      After having completed the first case of implantation of AM we proceed with this pilot study
      to determine in 20 consecutive patients undergone to pancreaticoduodenectomy (PD) with high
      risk of POPF, the efficacy of AM in reducing this event and the related morbidity.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Twenty consecutive patients candidated to PD regardless the diagnosis will be enrolled if
      presenting an high Fistula Risk Score. Enrollement will be done in O.R. after frozen section
      of the pancreas. The AM is provided by Fondazione Banca dei Tessuti di Treviso Onlus. The
      placenta is sourced from donors undergoing caesarean sections and processed shortly after
      retrieval, donors are evaluated according to Italian requirements. The AM is carefully
      detached from the chorion and rinsed with sterile saline solution, flattened on a
      nitrocellulose membrane filter (Merck Millipore), with its stromal side facing down, in
      contact with the filter. The AM is then immersed in a cocktail of antibiotics then cut into
      patches and immersed in cryopreservant solution. Cryopreservation was achieved using a
      programmable cryogenic freezer (Planer KryoSave Integra, 750-30), which triggers a controlled
      cooling rate. The AM patches were stored in vapor-phase liquid nitrogen. Thirty minutes
      before its use, the AM was defrozen and washed with saline. A 10x15cm MA patch was placed
      around the pancreatic anastomoses starting from the posterior surface. The caudal and the
      cranial flap were overlapped on the anterior surface to wrap the anastomosis. The membrane
      was than fixed with 4-0 Monocryl sutures at the jejunal surface and at the peri-pancreatic
      tissue. Then an end-to-side bilio-enteric anastomosis was carried out. The reconstruction was
      completed by an end-to-side antecolic duodenojejunostomy. At the end of the procedure, two
      drains were placed ventral and dorsal to the PJ, without friction with the AM.

      In the postoperative period will be evaluated: morbidity according to Clavien Dindo
      classification with attention to clinical relevant pancreatic fistula, bleeding, need of
      reintervention, surgical site infection, multi drug resistant infection and mortality. Costs
      and postoperative staying will be monitored as well.

      Student t test, Mann Whitney and Chi square will be used for statistical analysis.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Anticipated">March 2019</start_date>
  <completion_date type="Anticipated">November 1, 2019</completion_date>
  <primary_completion_date type="Anticipated">September 1, 2019</primary_completion_date>
  <phase>Early Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>Pilot study</intervention_model_description>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>postoperative complications</measure>
    <time_frame>up to 90 days after surgery</time_frame>
    <description>clinical relevant pancreatic fistula, intra-abdominal collection, acute pancreatitis, SSI, need for reintervention, mortality</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>correlation between microscopic pancreatic fibrosis and CR POPF</measure>
    <time_frame>90 days from surgery</time_frame>
    <description>the absence of microscopic fibrosis in a macroscopically soft pancreas may be related to higher risk of CR POPF and therefore may suggest implementation of anastomotic protecion (ie. the AM)</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Post Operative Pancreatic Fistula</condition>
  <condition>Pancreatic Resection</condition>
  <condition>Biological Dressing</condition>
  <arm_group>
    <arm_group_label>Amniotic Membrane implantation Arm</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>All consecutive patients undergone pancreaticoduodenectomy with high FRS will be treated with implantation of AM, by overlapping it over the pancreo-jejunal anastomosis.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Amniotic Membrane implantation</intervention_name>
    <description>Surgical procedure will be performed with Longemire Traverso technique. At the end of all pancreatic, biliary and duodenal anastomosis, the AM will be implanted.</description>
    <arm_group_label>Amniotic Membrane implantation Arm</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Age between 18 and 85 years Undergone to Pancreatico-duodenectomy with high FRS (&gt;=5)
        Adeguate consent

        Exclusion Criteria:

        Total pancreatectomy Pancreatic anastomosis different from pancreo-jejunal anastomosis
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>ISABELLA FRIGERIO</last_name>
    <role>Principal Investigator</role>
    <affiliation>PEDERZOLI HOSPITAL</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>ISABELLA FRIGERIO, MD PhD</last_name>
    <phone>+393392629661</phone>
    <email>IFRIGERIO@OSPEDALEPEDERZOLI.IT</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>GIOVANNI BUTTURINI, MD</last_name>
    <phone>00390456444283</phone>
    <email>ifrigerio@ospedalepederzoli.it</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Pederzoli Hospital</name>
      <address>
        <city>Peschiera Del Garda</city>
        <state>Verona</state>
        <zip>37019</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>ISABELLA FRIGERIO</last_name>
      <phone>00393392629661</phone>
      <email>isifrigerio@yahoo.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <reference>
    <citation>Pulvirenti A, Marchegiani G, Pea A, Allegrini V, Esposito A, Casetti L, Landoni L, Malleo G, Salvia R, Bassi C. Clinical Implications of the 2016 International Study Group on Pancreatic Surgery Definition and Grading of Postoperative Pancreatic Fistula on 775 Consecutive Pancreatic Resections. Ann Surg. 2018 Dec;268(6):1069-1075. doi: 10.1097/SLA.0000000000002362.</citation>
    <PMID>28678062</PMID>
  </reference>
  <reference>
    <citation>McMillan MT, Vollmer CM Jr, Asbun HJ, Ball CG, Bassi C, Beane JD, Berger AC, Bloomston M, Callery MP, Christein JD, Dixon E, Drebin JA, Castillo CF, Fisher WE, Fong ZV, Haverick E, House MG, Hughes SJ, Kent TS, Kunstman JW, Malleo G, McElhany AL, Salem RR, Soares K, Sprys MH, Valero V 3rd, Watkins AA, Wolfgang CL, Behrman SW. The Characterization and Prediction of ISGPF Grade C Fistulas Following Pancreatoduodenectomy. J Gastrointest Surg. 2016 Feb;20(2):262-76. doi: 10.1007/s11605-015-2884-2. Epub 2015 Jul 11.</citation>
    <PMID>26162925</PMID>
  </reference>
  <reference>
    <citation>Patel K, Teta A, Sukharamwala P, Thoens J, Szuchmacher M, DeVito P. External pancreatic duct stent reduces pancreatic fistula: a meta-analysis and systematic review. Int J Surg. 2014;12(8):827-32. doi: 10.1016/j.ijsu.2014.06.008. Epub 2014 Jul 6. Review.</citation>
    <PMID>25003575</PMID>
  </reference>
  <reference>
    <citation>Callery MP, Pratt WB, Kent TS, Chaikof EL, Vollmer CM Jr. A prospectively validated clinical risk score accurately predicts pancreatic fistula after pancreatoduodenectomy. J Am Coll Surg. 2013 Jan;216(1):1-14. doi: 10.1016/j.jamcollsurg.2012.09.002. Epub 2012 Nov 2.</citation>
    <PMID>23122535</PMID>
  </reference>
  <reference>
    <citation>Lin SD, Lai CS, Hou MF, Yang CC. Amnion overlay meshed skin autograft. Burns Incl Therm Inj. 1985 Jun;11(5):374-8.</citation>
    <PMID>3896420</PMID>
  </reference>
  <reference>
    <citation>Talmi YP, Sigler L, Inge E, Finkelstein Y, Zohar Y. Antibacterial properties of human amniotic membranes. Placenta. 1991 May-Jun;12(3):285-8.</citation>
    <PMID>1754577</PMID>
  </reference>
  <reference>
    <citation>Barski D, Gerullis H, Ecke T, Varga G, Boros M, Pintelon I, Timmermans JP, Winter A, Bagner JW, Otto T. Repair of a vesico-vaginal fistula with amniotic membrane - Step 1 of the IDEAL recommendations of surgical innovation. Cent European J Urol. 2015;68(4):459-61. doi: 10.5173/ceju.2015.683. Epub 2015 Nov 13.</citation>
    <PMID>26855802</PMID>
  </reference>
  <reference>
    <citation>Knight BC, Kausar A, Manu M, Ammori BA, Sherlock DJ, O'Reilly DA. Evaluation of surgical outcome scores according to ISGPS definitions in patients undergoing pancreatic resection. Dig Surg. 2010;27(5):367-74. doi: 10.1159/000313693. Epub 2010 Oct 13.</citation>
    <PMID>20938180</PMID>
  </reference>
  <verification_date>March 2019</verification_date>
  <study_first_submitted>March 25, 2019</study_first_submitted>
  <study_first_submitted_qc>March 25, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">March 26, 2019</study_first_posted>
  <last_update_submitted>March 25, 2019</last_update_submitted>
  <last_update_submitted_qc>March 25, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">March 26, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Casa di Cura Dott. Pederzoli</investigator_affiliation>
    <investigator_full_name>Isabella Frigerio</investigator_full_name>
    <investigator_title>MD, PhD</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pancreatic Fistula</mesh_term>
    <mesh_term>Fistula</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
    <ipd_description>UPON REQUEST</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

